fda semaglutide decision Hims & Hers stock falls 25% as curtails compounded GLP-1s Semaglutide shortage ends as FDA

Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients 138

Tirzepatide 15 mg (Mounjaro/Zepbound) Nausea in approximately 33 percent of participants in SURMOUNT trials

Their primary mechanisms of action include: Stimulating insulin secretion in a glucose-dependent manner (reducing hypoglycaemia risk) Suppressing glucagon release when blood glucose is elevated Slowing gastric emptying, which prolongs satiety Acting on appetite centres in the brain to reduce food intake Common GLP-1 medicines available in the UK include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)

Stress, sleep, insulin resistance, and age can all matter too